Sativex (nabiximols) - Jazz
temozolomide - Generic mfg.
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids (clinicaltrials.gov) - May 6, 2026 - P2 | N=120 | Recruiting | Sponsor: University of Birmingham | Trial primary completion date: Apr 2026 ➔ Sep 2026 
Trial primary completion date • Brain Cancer • Glioblastoma • Oncology • Solid Tumor • MGMT
http://clinicaltrials.gov/ct2/show/NCT05629702
 
May 6, 2026
 
Prev Next